Erythematotelangiectatic rosacea: The combination of 0.5% brimonidine tartrate gel and broadband pulse light therapy to reverse its effects.
Tatiana RusinaElena S SnarskayaPublished in: Journal of cosmetic dermatology (2020)
Rosacea is a common skin disease that is troublesome for both the patients and the dermatologists. Erythema, telangiectasia, papulopustular changes, and phymatous changes are the main problems faced by the patients and dermatologists in everyday practice. Due to the chronic and relapsing nature of the disease, patients are usually unsatisfied with conventional treatment methods. We report a case of a patient with rosacea, erythematotelangiectatic subtype with an eight-year history of progressive worsening and experience of combined therapy based on the broadband pulse light and topical 0.5% brimonidine tartrate gel. The effectiveness of the therapy was evaluated using multispectral skin imaging that enables to define morphological patterns of the pathological skin areas in a real-time mode as well as to create the map of hemoglobin distribution and to measure its concentration in the rosacea foci. In this case report, an efficacy and very good tolerability of the abovementioned treatment have been demonstrated.
Keyphrases
- end stage renal disease
- newly diagnosed
- case report
- ejection fraction
- multiple sclerosis
- healthcare
- prognostic factors
- peritoneal dialysis
- randomized controlled trial
- systematic review
- primary care
- wound healing
- stem cells
- rheumatoid arthritis
- clinical trial
- soft tissue
- mass spectrometry
- patient reported outcomes
- mesenchymal stem cells
- photodynamic therapy
- fluorescence imaging
- open label
- high density
- high speed
- quality improvement